Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Shoon and Zorx are one in the same! Both head cases.
$5-$10++
Please share your email with me richard@richrodriguezcpa.com
$5-$10+
You know I used to laugh when Trust would post values at $10-$20 per share and his optimism but now its leaning that way with the market indicators and forecast! Stay tuned!
$5-$10++
Hemostasis market thru the roof in coming years!
"The global hemostasis products market is estimated to secure a valuation of US$ 1.58 billion in 2023 and is predicted to surpass a valuation of US$ 2.65 billion by 2033. The market is anticipated to rise at a CAGR of 5.3% during the forecast period."
https://www.gminsights.com/industry-analysis/hemostasis-products-market
"The growing emphasis on providing technologically superior solutions will drive the business expansion" aka Hemostyp Gauze?
$5-$10++
Due your d/d!
Sorry wrong guy! Funny your the biggest fraud on the any of the boards!
$5+
Please do your due diligence review before every investment especially in the pink sheet penny trading market. UEEC has conducted clinical trial that supports the efficacy of the hemostyp gauze class III medical device. Proven superior to the J&J Surgicel product. Submission to the FDA PMA via the eStar program is imminent.
The daily trading volume is increasing.
https://uhpcorp.com/our-products/
https://www.clinicaltrials.gov/study/NCT03654560?tab=results
Recent news:
https://uhpcorp.com/united-health-products-reports-on-fda-application-status-2/
AI says...HemoStyp is a Class III medical device that is used in surgical procedures to help control bleeding. It is an all-natural product that contains specifically formulated regenerated oxidised cellulose gauze to help the hemostasis (clotting) process when positioned on a cut or wound.
$5-$10+
The eSTAR program by design enables PMA submitted medical devices to be reviewed in a more expeditious manner. The timeline certainly can still take up to 180 days from submission. It certainly is comprehensive. We shall see soon!
https://www.fda.gov/medical-devices/how-study-and-market-your-device/estar-program
$5-$10+
100,000 shares trade at the opening! Buckle up longs!
$5-$10+
Watch the premarket orders and this could be an interesting week.
$5-$10++
Don't like what anyone posts then no one is requiring you to reply or post! Please don't. Life is to short for you to worry about a company you are not even invested in.
$5-$10+
Your full of shit!
$5+
What an idiot you are! AND YOU DON'T OWN ANY SHARES IN UEEC!
That really shows how dumb you are!
$5-$10+
Yep read the ink! Shorties getting worried? Cover boys then call your attorney! The clock is running!!!
$5-$10+
Great news! Nice pr from CEO Brian Thom!
$5-$10+
Significant progress. QMC website has been updated.
https://www.qmc-health.com/
$5+
Well II spoke to Les Paul and others have voiced our displeasure with the job Stephen Squires performed. His lack of attentiveness to timely SEC filing did result in the QTMM delisting no doubt! That being said the company was well on its way to reporting but the SEC standard 180 filing demand letter was not sufficient for the company to comply with. I believe the technology will be purchased or we will eventually see a merger but I believe we as investors will see our investments recovered. Read into the posts here as you will but don't take one persons opinion! The company will once again be up listing IMO!
Stay tuned!
$5+
The punk doesn't have a bucket to pee in OR a job! IGNORED!
$5-$10+
Only ignorant fools ramble on with no meaning! Right Shoondale!
$5-$10+
Happy New Year Sporty! 2024 is our breakout year!
$5-$10+
Happy New Year posters. Lets start off 2024 with a pr? How about it Brian Thom?
$5-$10+
Boom!
$5-$10++
Just a bunch of old me posting with nothing better to do!
$5+
Your still full of shit!
$5-$10+
I still believe in the hemostyp gauze device II technology! Bottom line does it work in a surgical setting? The real value is in the foam and gel potential although this would require another clinical study IMO.
$5-$10+
What a loser you are! Who are you to criticize any CEO. How accomplished are you? Do you own shares in UEEC?
Talk is cheap and frivolous posts off topic are a waste of the boards time especially mine!
$5-$10+
Same to you Band Aid and it will be a Merry Christmas indeed!
$5-$10+
Buy as much as you can get your hands on!
$5-$10+
Who is RCA and do they have a track record of FDA submission of PMA's for medical device company's? You decide I have!!
https://www.rcainc.com/medical-device/
$5-$10+
Just the facts!
Sep. 06, 2022 12:37 PM ET United Health Products, Inc. (UEEC)By: Pranav Ghumatkar, SA News Editor
United Health Products (OTCPK:UEEC) has entered into a common stock purchase agreement to sell up to $10M of shares to White Lion Capital.
Under the terms, UHP will have the right, in its sole discretion, to sell shares to White Lion over a 36-month term.
Separately, the previously announced payments of ~$1M to be received by UHP from a former executive have been modified such that the Co. has received ~$0.2M and 2M shares of its common stock are being returned to the Co.
The proceeds of any sale of common stock to White Lion will be used for general corporate purposes.
Regarding the company’s FDA PMA application process, UHP continues to work with its intended manufacturing partner and its regulatory consultant, Regulatory Compliance Associates, to establish production and complete all necessary documentation.
Just to reiterate we have been guided by RCA who have former FDA personnel who are and have been in touch with FDA together with UEEC as Brian Thom has previously advised.
$5-$10+
Unknown but simply was an AI question that was asked. If AI is the real deal we should know very soon!
$5-$10+
WHAT DOES HEMPOSTYP STAND FOR?
AI says and who knows better.... It is a patented Neutralized Oxidized Regenerated Cellulose hemostatic agent that is used to control bleeding during surgical procedures 1. The product is currently under FDA review for pre-market approval 1.
I hope this helps!
AI😁
$5-$10+
Thank you and you have a good Thanksgiving weekend as well!
Prayers for all our world is going thru some tough times!
Keep the faith!
Remember bashers only bash a good stock! These posters are paid bashers who cannot find a job!
$5-$10+
Wishing the board a Happy Thanksgiving! Stay the course and focus on your family! UEEC lives and will be here tomorrow!
$5-$10+
Thanks as always to Philippe for posting short Interest,,,
SHORT INTEREST
DATE SHORT INTEREST % CHANGE AVG. DAILY SHARE VOL DAYS TO COVER SPLIT NEW ISSUE
10/31/2023 105,398 -16.56 163,138 1 No No
10/13/2023 126,319 24.36 226,281 1 No No
09/29/2023 101,575 3.75 118,939 1 No No
09/15/2023 97,900 -15.95 144,211 1 No No
08/31/2023 116,479 11.28 203,409 1 No No
08/15/2023 104,674 2.95 140,839 1 No No
07/31/2023 101,670 -15.02 131,125 1 No No
07/14/2023 119,643 0.06 222,407 1 No No
06/30/2023 119,572 -46.52 523,592 1 No No
06/15/2023 223,593 90.68 493,778 1 No No
$5-$10+
Get a job you suck at this one!
$5-$10+
He posts because he doesn't have a real job!
$5-$10+
I suspect as we saw in the third quarter White Lion Capital is increased their purchasing.
How about a production agreement. The hospital surgical area will soon IMO see more hemostyp gauze applications>
$5-$10+
Wonder why White Lion continues to invest other then because of their stock commitment agreement.
Date of Sale Title of Security Number Sold Consideration Received Purchaser/Recipient
January 2023 Common Stock 937,500 $187,500 of accrued liabilities Officers and consultants
January 2023 Common Stock 1,135,000 $249,399 in cash White Lion (1)
February 2023 Common Stock 1,000,000 $202,733 in cash White Lion (1)
March 2023 Common Stock 400,000 $73,173 in cash White Lion (1)
March 2023 Common Stock 400,000 $71,717 in cash White Lion (1)
March 2023 Common Stock 1,850,000 $462,500 to settle litigation Philip Forman
April 2023 Common Stock 979,688 $156,750 of accrued liabilities Officers and consultants
April 2023 Common Stock 450,000 $86,524 in cash White Lion (1)
May 2023 Common Stock 800,000 $139,797 in cash White Lion (1)
June 2023 Common Stock 1,200,000 $277,686 in cash White Lion (1)
June 2023 Common Stock 1,100,000 $311,820 in cash White Lion (1)
August 2023 Common Stock 500,000 $123,035 in cash White Lion (1)
September 2023 Common Stock 530,000 $124,358 in cash White Lion (1)
White Lion certainly believes in UEEC!
$5-$10
Thanks for the notice and nothing remarkable except reduction in a/p, accrued liabilities and accrued litigation settlement. All positives for our financial position.
$5-$10+